<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01190930</url>
  </required_header>
  <id_info>
    <org_study_id>AALL0932</org_study_id>
    <secondary_id>NCI-2011-02599</secondary_id>
    <secondary_id>CDR0000683227</secondary_id>
    <secondary_id>11-00080</secondary_id>
    <secondary_id>AALL0932</secondary_id>
    <secondary_id>AALL0932</secondary_id>
    <secondary_id>U10CA180886</secondary_id>
    <secondary_id>U10CA098543</secondary_id>
    <nct_id>NCT01190930</nct_id>
  </id_info>
  <brief_title>Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma</brief_title>
  <official_title>Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Oncology Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This partially randomized phase III trial studies the side effects of different combinations
      of risk-adapted chemotherapy regimens and how well they work in treating younger patients
      with newly diagnosed standard-risk acute lymphoblastic leukemia or B-lineage lymphoblastic
      lymphoma that is found only in the tissue or organ where it began (localized). Drugs used in
      chemotherapy work in different ways to stop the growth of cancer cells, either by killing the
      cells, by stopping them from dividing, or by stopping them from spreading. Giving more than
      one drug (combination chemotherapy), giving the drugs in different doses, and giving the
      drugs in different combinations may kill more cancer cells.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:

      l. To determine if a maintenance regimen containing weekly oral methotrexate at 40
      mg/m^2/week will result in an improved disease free survival (DFS) compared to that
      containing weekly oral methotrexate at 20 mg/m^2/week in the average-risk (AR) subset of
      patients with standard-risk B-precursor acute lymphoblastic leukemia (ALL). (Complete
      effective January 13, 2017) II. To determine whether a reduced-pulses maintenance regimen
      with vincristine (vincristine sulfate)/dexamethasone pulses delivered every 12 weeks can be
      used without adversely impacting DFS as compared to pulses given every 4 weeks in the AR
      subset of patients with standard risk B-precursor ALL.

      III. To confirm that patients in the low-risk (LR) subset of standard risk B-precursor ALL,
      based on clinical and cytogenetic features and minimal residual disease (MRD) criteria, can
      attain a 5 year DFS of at least 95% with either a P9904 based regimen that includes 6 courses
      of intermediate dose (1 g/m^2 over 24 hours) methotrexate without alkylating agents or
      anthracyclines (Arm LR-M), or an outpatient based regimen identical to that of AR patients
      with reduced vincristine/dexamethasone pulses at 12 week intervals during maintenance (Arm
      LR-C).

      IV. To provide standardized treatment and enhanced supportive care to children with
      standard-risk (SR) Down syndrome B-ALL in order to improve outcomes and facilitate further
      study of this biologically and clinically unique patient subgroup.

      V. To improve understanding of the biology of localized B-lineage lymphoblastic lymphoma
      (B-LLy) and Down syndrome (DS) B-LLy by obtaining biologic data, including fluorescence in
      situ hybridization (FISH) for recurrent cytogenetic lesions on paraffin specimen, and banking
      tissue for future research.

      VI. To describe the 5-year event free survival (EFS) and overall survival (OS) of patients
      with Murphy stage I and II B-LLy receiving modified AR B-ALL therapy.

      SECONDARY OBJECTIVES:

      I. To assess the burden of AR B-ALL therapy as measured by surveys of the child's quality of
      life, missed days of school/daycare/work by children and parents, family functioning,
      parental perception of the child's health vulnerability, physical functioning, and emotional
      distress, 1) overall at different time points during and at the end of therapy, and by 2)
      comparing children randomized to every 4 week vs. every 12 week dexamethasone/vincristine
      pulses during maintenance. (Closed to accrual as of April 19, 2013) II. To characterize the
      onset, severity, and natural history of vincristine associated neuropathy by physical
      therapists (or occupational therapists) in children undergoing therapy for AR B-ALL, 1)
      overall at different time points during and at the end of therapy, and by 2) comparing
      children randomized to every 4 week vs. every 12 week dexamethasone/vincristine pulses during
      maintenance. (Closed to accrual as of March 15, 2013)

      TERTIARY OBJECTIVES:

      I. To explore the correlation of minimal marrow disease (MMD) at diagnosis and outcome for
      patients with B-LLy. (Closed effective Amendment #5)

      OUTLINE:

      All patients receive induction therapy comprising intrathecal (IT) cytarabine on day 1;
      vincristine sulfate IV on days 1, 8, 15, and 22; dexamethasone orally (PO) or IV twice daily
      (BID) on days 1-28; pegaspargase IV over 1-2 hours on day 4; and IT methotrexate* on days 8
      and 29. Patients with Philadelphia chromosome-positive disease are eligible to transfer to
      COG-AALL0622 by day 15 of induction therapy and patients with high-risk (HR) or very
      high-risk (VHR) disease are eligible to transfer to a COG HR or VHR trial at the end of
      induction therapy. Patients with standard-risk disease with Down syndrome (DS) who have bone
      marrow minimal residual disease 0.01% are eligible to transfer to the DS stratum of the HR
      trial. Patients with induction failure (defined as M3 [&gt; 25% lymphoblasts] on day 29) may be
      eligible for the COG VHR-acute lymphoblastic leukemia study.

      NOTE: *Patients with DS also receive oral leucovorin calcium every 12 hours on days 10-11 and
      31-32.

      STANDARD-RISK WITH DOWN SYNDROME:

      Consolidation therapy (4 weeks): Patients receive vincristine sulfate IV on day 1;
      mercaptopurine PO on days 1-28; IT methotrexate on days 1, 8, and 15; and leucovorin calcium
      PO every 12 hours on days 3-4, 10-11, and 17-18. Interim maintenance I therapy (8 weeks):
      Patients receive vincristine sulfate IV and methotrexate IV over 2-15 minutes on days 1, 11,
      21, 31, and 41; IT methotrexate on day 31; and leucovorin calcium PO every 12 hours on days
      36-34. Delayed-intensification therapy (8 weeks): Patients receive dexamethasone PO or IV BID
      on days 1-7 and 15-21; vincristine sulfate IV and doxorubicin hydrochloride IV over 1-15
      minutes on days 1, 8, and 15; pegaspargase IV over 1-2 hours on day 4; cyclophosphamide IV
      over 30-60 minutes on day 29; thioguanine PO on days 29-42; cytarabine IV over 1-30 minutes
      or subcutaneously (SC) on days 29-32 and 33-39; IT methotrexate on days 1 and 29; and
      leucovorin calcium PO every 12 hours on days 3-4 and 31-32. Interim maintenance II therapy (8
      weeks): Patients receive vincristine sulfate IV and methotrexate IV over 2-15 minutes on days
      1, 11, 21, 31, and 41; IT methotrexate on days 1 and 31; and leucovorin calcium PO every 12
      hours on days 3-4 and 33-34. Maintenance therapy: Patients receive vincristine sulfate IV on
      day 1; dexamethasone PO BID on days 1-5; methotrexate PO on days 8, 15, 22, 29, 36, 43, 50,
      57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1. Courses
      repeat every 12 weeks for 2 years (timed from the start of interim maintenance I therapy).

      B-LLy:

      Consolidation therapy (4 weeks): Patients receive vincristine sulfate IV on day 1;
      mercaptopurine PO on days 1-28; IT methotrexate on days 1, 8, and 15; and leucovorin calcium
      PO every 12 hours on days 3-4, 10-11, and 17-18. Interim maintenance I therapy (8 weeks):
      Patients receive vincristine sulfate IV and methotrexate IV over 2-15 minutes on days 1, 11,
      21, 31, and 41; IT methotrexate on day 31; and leucovorin calcium PO every 12 hours on days
      36-34. Delayed-intensification therapy (8 weeks): Patients receive dexamethasone PO or IV BID
      on days 1-7 and 15-21; vincristine sulfate IV and doxorubicin hydrochloride IV over 1-15
      minutes on days 1, 8, and 15; pegaspargase IV over 1-2 hours on day 4; cyclophosphamide IV
      over 30-60 minutes on day 29; thioguanine PO on days 29-42; cytarabine IV over 1-30 minutes
      or subcutaneously (SC) on days 29-32 and 33-39; IT methotrexate on days 1 and 29; and
      leucovorin calcium PO every 12 hours on days 3-4 and 31-32. Interim maintenance II therapy (8
      weeks): Patients receive vincristine sulfate IV and methotrexate IV over 2-15 minutes on days
      1, 11, 21, 31, and 41; IT methotrexate on days 1 and 31; and leucovorin calcium PO every 12
      hours on days 3-4 and 33-34. Maintenance therapy: Patients receive vincristine sulfate IV on
      day 1; dexamethasone PO BID on days 1-5; methotrexate PO on days 8, 15, 22, 29, 36, 43, 50,
      57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1. Courses
      repeat every 4 weeks for 2 years (timed from the start of interim maintenance I therapy).

      AVERAGE-RISK:

      Consolidation therapy (4 weeks): Patients receive vincristine sulfate IV on day 1;
      mercaptopurine PO on days 1-28; and IT methotrexate on days 1, 8, and 15.Interim maintenance
      I therapy (8 weeks): Patients receive vincristine sulfate IV and methotrexate IV over 2-15
      minutes on days 1, 11, 21, 31, and 41 and IT methotrexate on day 31. Delayed intensification
      therapy (8 weeks): Patients receive dexamethasone PO or IV BID on days 1-7 and 15-21;
      vincristine sulfate IV and doxorubicin hydrochloride IV over 1-15 minutes on days 1, 8, and
      15; pegaspargase IV over 1-2 hours on day 4; cyclophosphamide IV over 30-60 minutes on day
      29; thioguanine PO on days 29-42; cytarabine IV over 1-30 minutes or SC on days 29-32 and
      36-39; and IT methotrexate on days 1 and 29. Interim maintenance II therapy (8 weeks):
      Patients receive vincristine sulfate IV and methotrexate IV over 2-15 minutes on days 1, 11,
      21, 31, and 41 and IT methotrexate on days 1 and 31. Maintenance therapy: Patients are
      randomized to 1 of 4 maintenance therapy treatment arms.

      Arm A: Patients receive vincristine sulfate IV on days 1, 29, and 57; dexamethasone PO BID on
      days 1-5, 29-33, and 57-61; methotrexate PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71,
      and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1.

      Arm B: Patients receive vincristine sulfate IV on days 1, 29, and 57; dexamethasone PO BID on
      days 1-5, 29-33, and 57-61; higher-dose methotrexate PO on days 8, 15, 22, 29, 36, 43, 50,
      57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1.

      Arm C: Patients receive vincristine sulfate IV on day 1; dexamethasone PO BID on days 1-5;
      methotrexate PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78; mercaptopurine PO on
      days 1-84; and IT methotrexate on day 1.

      Arm D: Patients receive vincristine sulfate IV on day 1; dexamethasone PO BID on days 1-5;
      higher-dose methotrexate PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78;
      mercaptopurine PO on days 1-84; and IT methotrexate on day 1.

      In all arms, maintenance therapy courses repeat every 12 weeks for 2 years for girls and for
      3 years for boys (timed from the start of interim maintenance I therapy).

      LOW-RISK: Patients are randomized to 1 of 2 treatment arms.

      Arm I (LR-M): Consolidation therapy (19 weeks): Beginning one week after completion of
      induction therapy, patients receive vincristine sulfate IV on days 15, 22, 78, and 85;
      methotrexate IV over 24 hours and IT methotrexate on days 8, 29, 50, 71, 92, and 113;
      leucovorin calcium PO or IV on days 9-10, 30-31, 51-52, 72-73, 93-94, and 114-115;
      dexamethasone PO BID or IV on days 15-21 and 78-84; and PO mercaptopurine on days
      1-133.Maintenance therapy: Patients receive vincristine sulfate IV on days 1 and 8;
      dexamethasone PO BID on days 1-7; methotrexate* PO on days 1, 8, 15, 22, 29, 36, 43, 50, 57,
      64, 71, 78, 85, 92, 99, and 106; and mercaptopurine PO on days 1-112. Courses repeat every 16
      weeks. Patients also receive IT methotrexate on days 1 and 85 (courses 1 and 4), day 57
      (courses 2 and 5), or day 29 (courses 3 and 6). Patients then receive course 7 comprising
      vincristine sulfate IV on days 1 and 8; dexamethasone PO BID on days 1-7; methotrexate PO on
      days 1, 8, 15, 22, 29, 36, 43, 50, 57, and 64; and mercaptopurine PO on days 1-70. Treatment
      continues for 2 and Â½ years (timed from the date of diagnosis).NOTE: *Patients do not
      receive methotrexate PO on the days that they receive IT methotrexate.

      Arm II (LR-C): Consolidation therapy (4 weeks): Patients receive vincristine sulfate IV on
      day 1; oral mercaptopurine on days 1-28; and IT methotrexate on days 1, 8, and 15. Interim
      maintenance I therapy (8 weeks): Patients receive vincristine sulfate IV and methotrexate IV
      over 2-15 minutes on days 1, 11, 21, 31, and 41 and IT methotrexate on day 31.
      Delayed-intensification therapy (8 weeks): Patients receive dexamethasone PO or IV BID on
      days 1-7 and 15-21; vincristine sulfate IV and doxorubicin hydrochloride IV over 1-15 minutes
      on days 1, 8, and 15; pegaspargase IV over 1-2 hours on day 4; cyclophosphamide IV over 30-60
      minutes on day 29; thioguanine PO on days 29-42; cytarabine IV over 1-30 minutes or SC on
      days 29-32 and 36-39; and IT methotrexate on days 1 and 29.Interim maintenance II therapy (8
      weeks): Patients receive vincristine sulfate IV and methotrexate IV over 2-15 minutes on days
      1, 11, 21, 31, and 41 and IT methotrexate on days 1 and 31. Maintenance therapy: Patients
      receive vincristine sulfate IV on day 1; dexamethasone PO BID on days 1-5; methotrexate PO on
      days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT
      methotrexate on day 1. Courses repeat every 12 weeks for 2 years for girls and for 3 years
      for boys (timed from the start of interim maintenance I therapy).

      After completion of study treatment, patients are followed up periodically for 10 years from
      study entry.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 9, 2010</start_date>
  <completion_date type="Anticipated">March 31, 2028</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease Free Survival (DFS) in Average Risk (AR) Patients Based on the Methotrexate Dose Randomization</measure>
    <time_frame>5.7 years</time_frame>
    <description>DFS is calculated as the time from randomization at the end of interim maintenance II to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DFS in Average Risk (AR) Patients Based on the Pulse Frequency Randomization</measure>
    <time_frame>5.7 years</time_frame>
    <description>DFS is calculated as the time from randomization at the end of interim maintenance II to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DFS in Low Risk (LR) Patients Based on Randomization to 1 of 2 Low-intensity Regimens</measure>
    <time_frame>5.1 years</time_frame>
    <description>DFS is calculated as the time from randomization at the end of Induction to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>DFS for SR Down Syndrome Patients With Standardized Treatment and Enhanced Supportive Care</measure>
    <time_frame>5.1 years</time_frame>
    <description>DFS is calculated as the time from end of Induction to first event (relapse, second malignancy, remission death) or date of last contact. The 5-year DFS and 95% confidence interval for these patients will be estimated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sample Collection of Central Path Review Slides in B-LLy Patients</measure>
    <time_frame>Up to 1 month</time_frame>
    <description>Percent of B-LLy patients who had adequate/usable samples of samples collected will be reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Event Free Survival (EFS) for B-LLy Patients</measure>
    <time_frame>5 years</time_frame>
    <description>EFS is calculated as the Time from study enrollment to first event (induction failure, relapse, second malignancy, remission death) or date of last contact. The 5-year EFS and 95% confidence interval for these patients will be estimated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Survival (OS) for B-LLy Patients</measure>
    <time_frame>5 years</time_frame>
    <description>OS is calculated as the time from study enrollment to death or date of last contact. The 5-year OS and 95% confidence interval for these patients will be estimated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: Emotional</measure>
    <time_frame>2 Months</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Emotional</measure>
    <time_frame>1 year</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Emotional</measure>
    <time_frame>1.7 years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Emotional</measure>
    <time_frame>2.5 years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients Overall at End of Therapy: Emotional</measure>
    <time_frame>3.2 years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Genetic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: Physical</measure>
    <time_frame>2 Months</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Physical</measure>
    <time_frame>1 Year</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Physical</measure>
    <time_frame>1.7 years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Physical</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients Overall at End of Therapy: Physical</measure>
    <time_frame>3.2 years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: School</measure>
    <time_frame>2 Months</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: School</measure>
    <time_frame>1 Year</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: School</measure>
    <time_frame>1.7 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): School</measure>
    <time_frame>2.4 years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients Overall at End of Therapy: School</measure>
    <time_frame>3.2 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: Social Functioning</measure>
    <time_frame>2 Months</time_frame>
    <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Social Functioning</measure>
    <time_frame>1 Year</time_frame>
    <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Social Functioning</measure>
    <time_frame>1.7 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Social Functioning</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients Overall at End of Therapy: Social Functioning</measure>
    <time_frame>3.2 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the Social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: Emotional</measure>
    <time_frame>1.7 years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Emotional</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: Emotional</measure>
    <time_frame>3.2 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: Physical</measure>
    <time_frame>1.7 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Physical</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: Physical</measure>
    <time_frame>3.2 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: School</measure>
    <time_frame>1.7 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): School</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: School</measure>
    <time_frame>3.2 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: Social Functioning</measure>
    <time_frame>1.7 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Social Functioning</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: Social Functioning</measure>
    <time_frame>3.2 Years</time_frame>
    <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Consolidation Therapy-Right</measure>
    <time_frame>2 Months</time_frame>
    <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Consolidation Therapy-Left</measure>
    <time_frame>2 Months</time_frame>
    <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 1: Right</measure>
    <time_frame>1 Year</time_frame>
    <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 1: Left</measure>
    <time_frame>1 Year</time_frame>
    <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Right</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Left</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL 12 Months Post Therapy: Right</measure>
    <time_frame>4.2 Years</time_frame>
    <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL 12 Months Post Therapy: Left</measure>
    <time_frame>4.2 Years</time_frame>
    <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Right</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for each randomization group will be reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Left</measure>
    <time_frame>2.4 Years</time_frame>
    <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for each randomization group will be reported.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">9350</enrollment>
  <condition>Acute Lymphoblastic Leukemia</condition>
  <condition>Adult B Lymphoblastic Lymphoma</condition>
  <condition>Ann Arbor Stage I B Lymphoblastic Lymphoma</condition>
  <condition>Ann Arbor Stage II B Lymphoblastic Lymphoma</condition>
  <condition>Childhood B Acute Lymphoblastic Leukemia</condition>
  <condition>Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1</condition>
  <condition>Childhood B Lymphoblastic Lymphoma</condition>
  <condition>Down Syndrome</condition>
  <condition>Hypodiploid B Acute Lymphoblastic Leukemia</condition>
  <condition>Philadelphia Chromosome Positive</condition>
  <arm_group>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive vincristine sulfate IV on days 1, 29, and 57; dexamethasone PO BID on days 1-5, 29-33, and 57-61; methotrexate PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive vincristine sulfate IV on days 1, 29, and 57; dexamethasone PO BID on days 1-5, 29-33, and 57-61; higher-dose methotrexate PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>See Detailed Description.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive vincristine sulfate IV on day 1; dexamethasone PO BID on days 1-5; methotrexate PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive vincristine sulfate IV on day 1; dexamethasone PO BID on days 1-5; higher-dose methotrexate PO on days 8, 15, 22, 29, 36, 43, 50, 57, 64, 71, and 78; mercaptopurine PO on days 1-84; and IT methotrexate on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive consolidation, interim maintenance I, delayed intensification, interim maintenance II, and maintenance therapy. See detailed description.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive consolidation and maintenance therapy. See detailed description.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>See Detailed Description</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyclophosphamide</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>(-)-Cyclophosphamide</other_name>
    <other_name>2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate</other_name>
    <other_name>Carloxan</other_name>
    <other_name>Ciclofosfamida</other_name>
    <other_name>Ciclofosfamide</other_name>
    <other_name>Cicloxal</other_name>
    <other_name>Clafen</other_name>
    <other_name>Claphene</other_name>
    <other_name>CP monohydrate</other_name>
    <other_name>CTX</other_name>
    <other_name>CYCLO-cell</other_name>
    <other_name>Cycloblastin</other_name>
    <other_name>Cycloblastine</other_name>
    <other_name>Cyclophospham</other_name>
    <other_name>Cyclophosphamid monohydrate</other_name>
    <other_name>Cyclophosphamide Monohydrate</other_name>
    <other_name>Cyclophosphamidum</other_name>
    <other_name>Cyclophosphan</other_name>
    <other_name>Cyclophosphane</other_name>
    <other_name>Cyclophosphanum</other_name>
    <other_name>Cyclostin</other_name>
    <other_name>Cyclostine</other_name>
    <other_name>Cytophosphan</other_name>
    <other_name>Cytophosphane</other_name>
    <other_name>Cytoxan</other_name>
    <other_name>Fosfaseron</other_name>
    <other_name>Genoxal</other_name>
    <other_name>Genuxal</other_name>
    <other_name>Ledoxina</other_name>
    <other_name>Mitoxan</other_name>
    <other_name>Neosar</other_name>
    <other_name>Revimmune</other_name>
    <other_name>Syklofosfamid</other_name>
    <other_name>WR- 138719</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cytarabine</intervention_name>
    <description>Given IT, IV, or SC</description>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>.beta.-Cytosine arabinoside</other_name>
    <other_name>1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone</other_name>
    <other_name>1-.beta.-D-Arabinofuranosylcytosine</other_name>
    <other_name>1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone</other_name>
    <other_name>1-Beta-D-arabinofuranosylcytosine</other_name>
    <other_name>1.beta.-D-Arabinofuranosylcytosine</other_name>
    <other_name>2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-</other_name>
    <other_name>2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-</other_name>
    <other_name>Alexan</other_name>
    <other_name>Ara-C</other_name>
    <other_name>ARA-cell</other_name>
    <other_name>Arabine</other_name>
    <other_name>Arabinofuranosylcytosine</other_name>
    <other_name>Arabinosylcytosine</other_name>
    <other_name>Aracytidine</other_name>
    <other_name>Aracytin</other_name>
    <other_name>Aracytine</other_name>
    <other_name>Beta-Cytosine Arabinoside</other_name>
    <other_name>CHX-3311</other_name>
    <other_name>Cytarabinum</other_name>
    <other_name>Cytarbel</other_name>
    <other_name>Cytosar</other_name>
    <other_name>Cytosine Arabinoside</other_name>
    <other_name>Cytosine-.beta.-arabinoside</other_name>
    <other_name>Cytosine-beta-arabinoside</other_name>
    <other_name>Erpalfa</other_name>
    <other_name>Starasid</other_name>
    <other_name>Tarabine PFS</other_name>
    <other_name>U 19920</other_name>
    <other_name>U-19920</other_name>
    <other_name>Udicil</other_name>
    <other_name>WR-28453</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>Given orally (PO) or IV</description>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>Aacidexam</other_name>
    <other_name>Adexone</other_name>
    <other_name>Aknichthol Dexa</other_name>
    <other_name>Alba-Dex</other_name>
    <other_name>Alin</other_name>
    <other_name>Alin Depot</other_name>
    <other_name>Alin Oftalmico</other_name>
    <other_name>Amplidermis</other_name>
    <other_name>Anemul mono</other_name>
    <other_name>Auricularum</other_name>
    <other_name>Auxiloson</other_name>
    <other_name>Baycadron</other_name>
    <other_name>Baycuten</other_name>
    <other_name>Baycuten N</other_name>
    <other_name>Cortidexason</other_name>
    <other_name>Cortisumman</other_name>
    <other_name>Decacort</other_name>
    <other_name>Decadrol</other_name>
    <other_name>Decadron</other_name>
    <other_name>Decadron DP</other_name>
    <other_name>Decalix</other_name>
    <other_name>Decameth</other_name>
    <other_name>Decasone R.p.</other_name>
    <other_name>Dectancyl</other_name>
    <other_name>Dekacort</other_name>
    <other_name>Deltafluorene</other_name>
    <other_name>Deronil</other_name>
    <other_name>Desamethasone</other_name>
    <other_name>Desameton</other_name>
    <other_name>Dexa-Mamallet</other_name>
    <other_name>Dexa-Rhinosan</other_name>
    <other_name>Dexa-Scheroson</other_name>
    <other_name>Dexa-sine</other_name>
    <other_name>Dexacortal</other_name>
    <other_name>Dexacortin</other_name>
    <other_name>Dexafarma</other_name>
    <other_name>Dexafluorene</other_name>
    <other_name>Dexalocal</other_name>
    <other_name>Dexamecortin</other_name>
    <other_name>Dexameth</other_name>
    <other_name>Dexamethasone Intensol</other_name>
    <other_name>Dexamethasonum</other_name>
    <other_name>Dexamonozon</other_name>
    <other_name>Dexapos</other_name>
    <other_name>Dexinoral</other_name>
    <other_name>Dexone</other_name>
    <other_name>Dinormon</other_name>
    <other_name>Fluorodelta</other_name>
    <other_name>Fortecortin</other_name>
    <other_name>Gammacorten</other_name>
    <other_name>Hexadecadrol</other_name>
    <other_name>Hexadrol</other_name>
    <other_name>Lokalison-F</other_name>
    <other_name>Loverine</other_name>
    <other_name>Methylfluorprednisolone</other_name>
    <other_name>Millicorten</other_name>
    <other_name>Mymethasone</other_name>
    <other_name>Orgadrone</other_name>
    <other_name>Spersadex</other_name>
    <other_name>TaperDex</other_name>
    <other_name>Visumetazone</other_name>
    <other_name>ZoDex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Doxorubicin Hydrochloride</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI)</other_name>
    <other_name>ADM</other_name>
    <other_name>Adriacin</other_name>
    <other_name>Adriamycin</other_name>
    <other_name>Adriamycin Hydrochloride</other_name>
    <other_name>Adriamycin PFS</other_name>
    <other_name>Adriamycin RDF</other_name>
    <other_name>ADRIAMYCIN, HYDROCHLORIDE</other_name>
    <other_name>Adriamycine</other_name>
    <other_name>Adriblastina</other_name>
    <other_name>Adriblastine</other_name>
    <other_name>Adrimedac</other_name>
    <other_name>Chloridrato de Doxorrubicina</other_name>
    <other_name>DOX</other_name>
    <other_name>DOXO-CELL</other_name>
    <other_name>Doxolem</other_name>
    <other_name>Doxorubicin HCl</other_name>
    <other_name>Doxorubicin.HCl</other_name>
    <other_name>Doxorubin</other_name>
    <other_name>Farmiblastina</other_name>
    <other_name>FI 106</other_name>
    <other_name>FI-106</other_name>
    <other_name>hydroxydaunorubicin</other_name>
    <other_name>Rubex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Laboratory Biomarker Analysis</intervention_name>
    <description>Correlative studies</description>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Leucovorin Calcium</intervention_name>
    <description>Given PO</description>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>Adinepar</other_name>
    <other_name>Calcifolin</other_name>
    <other_name>Calcium (6S)-Folinate</other_name>
    <other_name>Calcium Folinate</other_name>
    <other_name>Calcium Leucovorin</other_name>
    <other_name>Calfolex</other_name>
    <other_name>Calinat</other_name>
    <other_name>Cehafolin</other_name>
    <other_name>Citofolin</other_name>
    <other_name>Citrec</other_name>
    <other_name>citrovorum factor</other_name>
    <other_name>Cromatonbic Folinico</other_name>
    <other_name>Dalisol</other_name>
    <other_name>Disintox</other_name>
    <other_name>Divical</other_name>
    <other_name>Ecofol</other_name>
    <other_name>Emovis</other_name>
    <other_name>Factor, Citrovorum</other_name>
    <other_name>Flynoken A</other_name>
    <other_name>Folaren</other_name>
    <other_name>Folaxin</other_name>
    <other_name>FOLI-cell</other_name>
    <other_name>Foliben</other_name>
    <other_name>Folidan</other_name>
    <other_name>Folidar</other_name>
    <other_name>Folinac</other_name>
    <other_name>Folinate Calcium</other_name>
    <other_name>folinic acid</other_name>
    <other_name>Folinic Acid Calcium Salt Pentahydrate</other_name>
    <other_name>Folinoral</other_name>
    <other_name>Folinvit</other_name>
    <other_name>Foliplus</other_name>
    <other_name>Folix</other_name>
    <other_name>Imo</other_name>
    <other_name>Lederfolat</other_name>
    <other_name>Lederfolin</other_name>
    <other_name>Leucosar</other_name>
    <other_name>leucovorin</other_name>
    <other_name>Rescufolin</other_name>
    <other_name>Rescuvolin</other_name>
    <other_name>Tonofolin</other_name>
    <other_name>Wellcovorin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mercaptopurine</intervention_name>
    <description>Given PO</description>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>3H-Purine-6-thiol</other_name>
    <other_name>6 MP</other_name>
    <other_name>6 Thiohypoxanthine</other_name>
    <other_name>6 Thiopurine</other_name>
    <other_name>6-Mercaptopurine</other_name>
    <other_name>6-Mercaptopurine Monohydrate</other_name>
    <other_name>6-MP</other_name>
    <other_name>6-Purinethiol</other_name>
    <other_name>6-Thiopurine</other_name>
    <other_name>6-Thioxopurine</other_name>
    <other_name>6H-Purine-6-thione, 1,7-dihydro- (9CI)</other_name>
    <other_name>7-Mercapto-1,3,4,6-tetrazaindene</other_name>
    <other_name>Alti-Mercaptopurine</other_name>
    <other_name>Azathiopurine</other_name>
    <other_name>BW 57-323H</other_name>
    <other_name>Flocofil</other_name>
    <other_name>Ismipur</other_name>
    <other_name>Leukerin</other_name>
    <other_name>Leupurin</other_name>
    <other_name>Mercaleukim</other_name>
    <other_name>Mercaleukin</other_name>
    <other_name>Mercaptina</other_name>
    <other_name>Mercaptopurinum</other_name>
    <other_name>Mercapurin</other_name>
    <other_name>Mern</other_name>
    <other_name>NCI-C04886</other_name>
    <other_name>Puri-Nethol</other_name>
    <other_name>Purimethol</other_name>
    <other_name>Purine, 6-mercapto-</other_name>
    <other_name>Purine-6-thiol (8CI)</other_name>
    <other_name>Purine-6-thiol, monohydrate</other_name>
    <other_name>Purinethiol</other_name>
    <other_name>Purinethol</other_name>
    <other_name>U-4748</other_name>
    <other_name>WR-2785</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methotrexate</intervention_name>
    <description>Given IT, PO, or IV</description>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>Abitrexate</other_name>
    <other_name>Alpha-Methopterin</other_name>
    <other_name>Amethopterin</other_name>
    <other_name>Brimexate</other_name>
    <other_name>CL 14377</other_name>
    <other_name>CL-14377</other_name>
    <other_name>Emtexate</other_name>
    <other_name>Emthexat</other_name>
    <other_name>Emthexate</other_name>
    <other_name>Farmitrexat</other_name>
    <other_name>Fauldexato</other_name>
    <other_name>Folex</other_name>
    <other_name>Folex PFS</other_name>
    <other_name>Lantarel</other_name>
    <other_name>Ledertrexate</other_name>
    <other_name>Lumexon</other_name>
    <other_name>Maxtrex</other_name>
    <other_name>Medsatrexate</other_name>
    <other_name>Metex</other_name>
    <other_name>Methoblastin</other_name>
    <other_name>Methotrexate LPF</other_name>
    <other_name>Methotrexate Methylaminopterin</other_name>
    <other_name>Methotrexatum</other_name>
    <other_name>Metotrexato</other_name>
    <other_name>Metrotex</other_name>
    <other_name>Mexate</other_name>
    <other_name>Mexate-AQ</other_name>
    <other_name>MTX</other_name>
    <other_name>Novatrex</other_name>
    <other_name>Rheumatrex</other_name>
    <other_name>Texate</other_name>
    <other_name>Tremetex</other_name>
    <other_name>Trexeron</other_name>
    <other_name>Trixilem</other_name>
    <other_name>WR-19039</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pegaspargase</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>L-Asparaginase with Polyethylene Glycol</other_name>
    <other_name>Oncaspar</other_name>
    <other_name>Oncaspar-IV</other_name>
    <other_name>PEG-Asparaginase</other_name>
    <other_name>PEG-L-Asparaginase</other_name>
    <other_name>PEG-L-Asparaginase (Enzon - Kyowa Hakko)</other_name>
    <other_name>PEGLA</other_name>
    <other_name>Polyethylene Glycol L-Asparaginase</other_name>
    <other_name>Polyethylene Glycol-L-Asparaginase</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thioguanine</intervention_name>
    <description>Given PO</description>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>2-Amino 6MP</other_name>
    <other_name>2-Amino-1,7-dihydro-6H-purine-6-thione</other_name>
    <other_name>2-Amino-6-mercaptopurine</other_name>
    <other_name>2-Amino-6-purinethiol</other_name>
    <other_name>2-Aminopurin-6-thiol</other_name>
    <other_name>2-Aminopurine-6(1H)-thione</other_name>
    <other_name>2-Aminopurine-6-thiol</other_name>
    <other_name>2-Aminopurine-6-thiol Hemihydrate</other_name>
    <other_name>2-Mercapto-6-aminopurine</other_name>
    <other_name>6-Amino-2-mercaptopurine</other_name>
    <other_name>6-Mercapto-2-aminopurine</other_name>
    <other_name>6-Mercaptoguanine</other_name>
    <other_name>6-TG</other_name>
    <other_name>6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI)</other_name>
    <other_name>BW 5071</other_name>
    <other_name>Lanvis</other_name>
    <other_name>Tabloid</other_name>
    <other_name>Thioguanine Hemihydrate</other_name>
    <other_name>Thioguanine Hydrate</other_name>
    <other_name>Tioguanin</other_name>
    <other_name>Tioguanine</other_name>
    <other_name>Wellcome U3B</other_name>
    <other_name>WR-1141</other_name>
    <other_name>X 27</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vincristine Sulfate</intervention_name>
    <description>Given IV</description>
    <arm_group_label>Arm A (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm B-LLy (4-week cycle maintenance)</arm_group_label>
    <arm_group_label>Arm C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm D (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-C (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm LR-M (risk-adapted chemotherapy)</arm_group_label>
    <arm_group_label>Arm SR DS (12-week cycle maintenance)</arm_group_label>
    <other_name>Kyocristine</other_name>
    <other_name>Leurocristine sulfate</other_name>
    <other_name>Leurocristine, sulfate</other_name>
    <other_name>Oncovin</other_name>
    <other_name>Vincasar</other_name>
    <other_name>Vincosid</other_name>
    <other_name>Vincrex</other_name>
    <other_name>Vincristine, sulfate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  B-ALL patients must be enrolled on AALL08B1 or APEC14B1 (if open for the
             classification of newly diagnosed ALL patients) prior to treatment and enrollment on
             AALL0932

               -  Note: B-LLy patients are not eligible for AALL08B1, and can enroll directly onto
                  AALL0932

          -  B-ALL patients must have an initial white blood cell count &lt; 50,000/uL

          -  Patients must have newly diagnosed National Cancer Institute (NCI) Standard Risk B-ALL
             or B-LLy Murphy stages I or II; patients with Down syndrome are also eligible

               -  Note: for B-LLy patients with tissue available for flow cytometry, the criterion
                  for diagnosis should be analogous to B-ALL; for tissue processed by other means
                  (i.e. paraffin blocks), the methodology and criteria for immunophenotypic
                  analysis to establish the diagnosis of B-LLy defined by the submitting
                  institution will be accepted

          -  All patients and/or their parents or legal guardians must sign a written informed
             consent

          -  All institutional, Food and Drug Administration (FDA), and NCI requirements for human
             studies must be met

        Exclusion Criteria:

          -  With the exception of steroid pretreatment (defined below) or the administration of
             intrathecal cytarabine, patients must not have received any prior cytotoxic
             chemotherapy for either the current diagnosis of B-ALL or B-LLy or for any cancer
             diagnosed prior to initiation of protocol therapy on AALL0932

               -  Patients receiving prior steroid therapy may be eligible for AALL0932

          -  Patients with central nervous system 3 (CNS3) leukemia

               -  CNS status must be known prior to enrollment; (Note: the CNS status must be
                  determined based on a sample obtained prior to administration of any systemic or
                  intrathecal chemotherapy, except for steroid pretreatment); B-LLy patients with
                  CNS3 disease are not eligible for this protocol or the COG HR ALL protocol; it is
                  recommended that intrathecal cytarabine be administered at the time of the
                  diagnostic lumbar puncture; this is usually done at the time of the diagnostic
                  bone marrow or venous line placement to avoid a second lumbar puncture; this is
                  allowed prior to registration; systemic chemotherapy must begin within 72 hours
                  of the first dose of intrathecal therapy

          -  B-ALL patients with testicular leukemia are not eligible for AALL0932

          -  For B-LLy patients the following additional exclusion criteria apply:

               -  T-lymphoblastic lymphoma

               -  Morphologically unclassifiable lymphoma

               -  Absence of both B-cell and T-cell phenotype markers in a case submitted as
                  lymphoblastic lymphoma

               -  CNS3-positive disease or testicular involvement

               -  M2 (5% - 25% blasts) or M3 (&gt; 25% blasts) marrow

               -  Female patients who are pregnant are ineligible

               -  Lactating females are not eligible unless they have agreed not to breastfeed
                  their infants

               -  Female patients of childbearing potential are not eligible unless a negative
                  pregnancy test result has been obtained

               -  Sexually active patients of reproductive potential are not eligible unless they
                  have agreed to use an effective contraceptive method for the duration of their
                  study participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne L Angiolillo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Oncology Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alabama at Birmingham Cancer Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>USA Health Strada Patient Care Center</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Alaska Medical Center</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardon Children's Medical Center</name>
      <address>
        <city>Mesa</city>
        <state>Arizona</state>
        <zip>85202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phoenix Childrens Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Banner University Medical Center - Tucson</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202-3591</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Downey Medical Center</name>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>City of Hope Comprehensive Cancer Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miller Children's and Women's Hospital Long Beach</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mattel Children's Hospital UCLA</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCLA / Jonsson Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Valley Children's Hospital</name>
      <address>
        <city>Madera</city>
        <state>California</state>
        <zip>93636</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital and Research Center at Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609-1809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente-Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lucile Packard Children's Hospital Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sutter Medical Center Sacramento</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California Davis Comprehensive Cancer Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rady Children's Hospital - San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center -San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center-Parnassus</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Medical Center-Mission Bay</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Barbara Cottage Hospital</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfred I duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Broward Health Medical Center</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lee Memorial Health System</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Golisano Children's Hospital of Southwest Florida</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida Health Science Center - Gainesville</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Regional Hospital/Joe DiMaggio Children's Hospital</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic-Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Miller School of Medicine-Sylvester Cancer Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nicklaus Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33155</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Miami Cancer Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AdventHealth Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arnold Palmer Hospital for Children</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic - Orlando</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UF Cancer Center at Orlando Health</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic - Pensacola</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins All Children's Hospital</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital/Children's Hospital-Tampa</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Mary's Hospital</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Healthcare of Atlanta - Egleston</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augusta University Medical Center</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Health University Medical Center</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Hawaii Cancer Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kapiolani Medical Center for Women and Children</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tripler Army Medical Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96859</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Mountain States Tumor Institute</name>
      <address>
        <city>Boise</city>
        <state>Idaho</state>
        <zip>83712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lurie Children's Hospital-Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Illinois</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Comprehensive Cancer Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocate Children's Hospital-Oak Lawn</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocate Children's Hospital-Park Ridge</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advocate Lutheran General Hospital</name>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Jude Midwest Affiliate</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Illinois University School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Hospital and Health Care Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Blank Children's Hospital</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa/Holden Comprehensive Cancer Center</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky/Markey Cancer Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Children's Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tulane University Health Sciences Center</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ochsner Medical Center Jefferson</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eastern Maine Medical Center</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maine Children's Cancer Program</name>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <zip>04074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland/Greenebaum Cancer Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sinai Hospital of Baltimore</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University/Sidney Kimmel Cancer Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889-5600</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Floating Hospital for Children at Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital Cancer Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Medical Center - University Campus</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>C S Mott Children's Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University/Karmanos Cancer Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ascension Saint John Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan State University Clinical Center</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48824-7016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hurley Medical Center</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helen DeVos Children's Hospital at Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bronson Methodist Hospital</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalamazoo Center for Medical Studies</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaumont Children's Hospital-Royal Oak</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital-Royal Oak</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospitals and Clinics of Minnesota - Minneapolis</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota/Masonic Cancer Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia Regional</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospitals and Clinics</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardinal Glennon Children's Medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital Saint Louis</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital and Medical Center of Omaha</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center of Southern Nevada</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nevada Cancer Research Foundation CCOP</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunrise Hospital and Medical Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alliance for Childhood Diseases/Cure 4 the Kids Foundation</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Summerlin Hospital Medical Center</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Barnabas Medical Center</name>
      <address>
        <city>Livingston</city>
        <state>New Jersey</state>
        <zip>07039</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Peter's University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Regional Medical Center</name>
      <address>
        <city>Paterson</city>
        <state>New Jersey</state>
        <zip>07503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Overlook Hospital</name>
      <address>
        <city>Summit</city>
        <state>New Jersey</state>
        <zip>07902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of New Mexico Cancer Center</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center - Moses Campus</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooklyn Hospital Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Winthrop Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Steven and Alexandra Cohen Children's Medical Center of New York</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laura and Isaac Perlmutter Cancer Center at NYU Langone</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYP/Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Medical Center</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>State University of New York Upstate Medical University</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Medical College</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mission Hospital</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UNC Lineberger Comprehensive Cancer Center</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center/Levine Cancer Institute</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Presbyterian Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Carolina University</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Broadway Medical Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Medical Center of Akron</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rainbow Babies and Childrens Hospital</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dayton Children's Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Toledo Hospital/Toledo Children's Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Children's Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Natalie Warren Bryant Cancer Center at Saint Francis</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Emanuel Children's Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Emanuel Hospital and Health Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital-Cedar Crest</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital - Muhlenberg</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn State Children's Hospital</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Christopher's Hospital for Children</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh of UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prisma Health Richland Hospital</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BI-LO Charities Children's Cancer Center</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Cancer Treatment Center</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford USD Medical Center - Sioux Falls</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57117-5134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>T C Thompson Children's Hospital</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Tennessee Childrens Hospital</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37916</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Jude Children's Research Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital at TriStar Centennial</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University/Ingram Cancer Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Tech University Health Sciences Center-Amarillo</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dell Children's Medical Center of Central Texas</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Driscoll Children's Hospital</name>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78411</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical City Dallas Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Southwestern/Simmons Cancer Center-Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El Paso Children's Hospital</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cook Children's Medical Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Covenant Children's Hospital</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79410</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMC Cancer Center / UMC Health System</name>
      <address>
        <city>Lubbock</city>
        <state>Texas</state>
        <zip>79415</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vannie Cook Children's Clinic</name>
      <address>
        <city>McAllen</city>
        <state>Texas</state>
        <zip>78503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Children's Hospital of South Texas</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott and White Memorial Hospital</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Children's Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Vermont and State Agricultural College</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Cancer Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of The King's Daughters</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center - Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708-2197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University/Massey Cancer Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carilion Clinic Children's Hospital</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Sacred Heart Medical Center and Children's Hospital</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mary Bridge Children's Hospital and Health Center</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Madigan Army Medical Center</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Virginia University Charleston Division</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Virginia University Healthcare</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Vincent Hospital Cancer Center Green Bay</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin Hospital and Clinics</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Medical Center-Marshfield</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>John Hunter Children's Hospital</name>
      <address>
        <city>Hunter Regional Mail Centre</city>
        <state>New South Wales</state>
        <zip>2310</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sydney Children's Hospital</name>
      <address>
        <city>Randwick</city>
        <state>New South Wales</state>
        <zip>2031</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital-Brisbane</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <zip>4029</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queensland Children's Hospital</name>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's and Children's Hospital-Adelaide</name>
      <address>
        <city>North Adelaide</city>
        <state>South Australia</state>
        <zip>5006</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Monash Medical Center-Clayton Campus</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Children's Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3052</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital for Children</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3B 6A8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>British Columbia Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CancerCare Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 0V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Janeway Child Health Centre</name>
      <address>
        <city>Saint John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 3V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McMaster Children's Hospital at Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kingston Health Sciences Centre</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <zip>K7L 2V7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Eastern Ontario</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Montreal Children's Hospital of the MUHC</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3H 1P3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Allan Blair Cancer Centre</name>
      <address>
        <city>Regina</city>
        <state>Saskatchewan</state>
        <zip>S4T 7T1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saskatoon Cancer Centre</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <zip>S7N 4H4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Our Lady's Children's Hospital</name>
      <address>
        <city>Dublin</city>
        <state>Co Dublin</state>
        <zip>12</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Starship Children's Hospital</name>
      <address>
        <city>Grafton</city>
        <state>Auckland</state>
        <zip>1145</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christchurch Hospital</name>
      <address>
        <city>Christchurch</city>
        <zip>8011</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Jorge Children's Hospital</name>
      <address>
        <city>San Juan</city>
        <zip>00912</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Pediatric Hospital</name>
      <address>
        <city>San Juan</city>
        <zip>00926</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swiss Pediatric Oncology Group - Geneva</name>
      <address>
        <city>Geneva</city>
        <zip>1205</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swiss Pediatric Oncology Group - Lausanne</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Ireland</country>
    <country>New Zealand</country>
    <country>Puerto Rico</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 27, 2010</study_first_submitted>
  <study_first_submitted_qc>August 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2010</study_first_posted>
  <results_first_submitted>March 25, 2020</results_first_submitted>
  <results_first_submitted_qc>June 5, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 23, 2020</results_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
    <mesh_term>Leukemia, Lymphoid</mesh_term>
    <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Philadelphia Chromosome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Leucovorin</mesh_term>
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Cytarabine</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Cyclophosphamide</mesh_term>
    <mesh_term>Doxorubicin</mesh_term>
    <mesh_term>Liposomal doxorubicin</mesh_term>
    <mesh_term>Methotrexate</mesh_term>
    <mesh_term>Vincristine</mesh_term>
    <mesh_term>Asparaginase</mesh_term>
    <mesh_term>Mercaptopurine</mesh_term>
    <mesh_term>Pegaspargase</mesh_term>
    <mesh_term>Thioguanine</mesh_term>
    <mesh_term>Ichthammol</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Calcium</mesh_term>
    <mesh_term>2-Aminopurine</mesh_term>
    <mesh_term>Levoleucovorin</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 26, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/30/NCT01190930/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)</recruitment_details>
      <pre_assignment_details>Patients were stratified between 2 disease groups (B-ALL and B-LLY) for Induction and then risk assigned treatment based upon the patient's response.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>B-ALL</title>
          <description>All patients receive induction therapy comprising intrathecal (IT) cytarabine on day 1; vincristine sulfate IV on days 1, 8, 15, and 22; dexamethasone orally (PO) or IV twice daily (BID) on days 1-28; pegaspargase IV over 1-2 hours on day 4; and IT methotrexate on days 8 and 29. Patients with DS also receive leucovorin calcium every 12 hours on days 10-11 and 21-32. Patients with Philadelphia chromosome-positive disease are eligible to transfer to COG-AALL0622 by day 15 of induction therapy and patients with high-risk (HR) or very high-risk (VHR) disease are eligible to transfer to a COG HR or VHR trial at the end of induction therapy. Patients with standard-risk disease with Down syndrome (DS) who have bone marrow minimal residual disease 0.01% are eligible to transfer to the DS stratum of the HR trial. Patients with induction failure (defined as M3 [&gt; 25% lymphoblasts] on day 29) may be eligible for the COG VHR-acute lymphoblastic leukemia study.</description>
        </group>
        <group group_id="P2">
          <title>B-LLy</title>
          <description>Induction: same trt as B-ALL; Consolidation (4 wks): vincristine sulfate day 1; mercaptopurine days 1-28; IT methotrexate (MTX) days 1/8/15; leucovorin calcium days 3-4,10-11,17-18 Interim maintenance I (8 wks): vincristine sulfate and MTX 2-15 min days 1/11/21/31/41; IT MTX day 31; leucovorin calcium days 33-34 Delayed-intensification (8 wks): dexamethasone days 1-7 and 15-21; vincristine sulfate and doxorubicin hydrochloride on days 1/8/15; pegaspargase 1-2 hrs day 4; cyclophosphamide day 29; thioguanine days 29-42; cytarabine 29-32, 33-39; IT MTX days 1/29; and leucovorin calcium days 3-4, 31-32 Interim maintenance II (8 wks): vincristine sulfate and MTX days 1/11/21/31/41; IT MTX days 1/31; and leucovorin calcium days 3-4, 33/34 Maintenance: vincristine sulfate day 1; dexamethasone days 1-5; MTX weekly days 8-78; mercaptopurine days 1-84; and IT MTX day 1. Courses repeat every 4 wks for 2 yrs (from the start of IMI therapy).</description>
        </group>
        <group group_id="P3">
          <title>B-ALL Average Risk</title>
          <description>Consolidation (4 wks): vincristine (VIN) day (d) 1; mercaptopurine (MP) d 1-28; IT MTX d 1/8/15; leucovorin (LV) d 3-4/10-11/17-18 Int. maint. I (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 31; LV d 33-34 Delayed-intensification (8 wks): dexamethasone (DEX) d 1-7/15-21; VIN and doxorubicin d 1/8/15; pegaspargase d 4; cyclophosphamide d 29; thioguanine d 29-42; cytarabine d 29-32/33-39; IT MTX d 1/29; LV d 3-4/31-32 Int. maint. II (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 1/31; LV d 3-4/33-34</description>
        </group>
        <group group_id="P4">
          <title>Standard Risk With Down Syndrome</title>
          <description>Consolidation (4 w): vincristine (VIN) d1; MP d1-28; IT methotrexate (MTX) d1/8/15; leucovorin (LV) d3-4/10-11/17-18 Interim maintenance I (8 wks): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d31; LV d36-34 Delayed-intensification (8 wks): Patients receive dexamethasone (DEX) d1-7/15-21; VIN &amp; doxorubicin d1/8/15; pegaspargase d4; cyclophosphamide d29; thioguanine d 29-42; cytarabine d29-32/33-39; IT MTX d1/29; and LV d3-4/31-32 Interim maintenance II (8 wks): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d1/31; and LV d3-4/33-34 Maintenance: VIN d1; DEX d1-5; PO MTX wkly d8-78; MP d1-84; and IT MTX d1. Courses repeat every 12 wks for 2 years (timed from the start of interim maintenance I therapy).</description>
        </group>
        <group group_id="P5">
          <title>B-ALL Low Risk Arm I (LR-M)</title>
          <description>Consolidation (19 w): vincristine (VIN) day(d) 15/22/78/85; IV/IT methotrexate (MTX) d8/29/50/71/92/113; leucovorin (LV) d9-10/30-31/51-52/72-73/93-94/114-115; dexamethasone (DEX) d15-21/78-84; mercaptopurine (MP) d 1-133. Maint.: VIN d1/8; DEX d1-7; MTX* PO wkly d1-106; MP d 1-112. Repeat every 16 w until 2.5 yrs from dx. IT MTX d1/85 (course 1&amp;4), d 57 (course 2&amp;5), d29 (course 3&amp;6). Course 7: VIN d1/8; DEX d 1-7; MTX PO wkly d8-64; and MP d1-70. *Patients do not receive MTX PO on d w/ IT MTX.</description>
        </group>
        <group group_id="P6">
          <title>B-ALL Low Risk Arm II (LR-C)</title>
          <description>Consolidation (4 w): VIN d1; MP d1-28; IT MTX d1/8/15 Interim Maint. I (8 w): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d31 Delayed-intensification (8 w): DEX d1-7/15-21; VIN &amp; doxorubicin d1/8/15; pegaspargase d4; cyclophosphamide d29; thioguanine d 29-42; cytarabine d29-32/36-39; IT MTX d1/29 Interim Maint. II (8 w): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d1/31 Maint.: VIN d1; DEX d1-5; MTX PO wkly d22-78; MP d 1-84; IT MTX d1. Rpt every 12 w for 2 yrs:girls, 3 yrs:boys from start IM1</description>
        </group>
        <group group_id="P7">
          <title>B-ALL Average Risk-Arm A</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1/29/57; DEX d 1-5/29-33/57-61; MTX weekly d 8-78; MP d 1+P8:W8-84; and IT MTX d 1</description>
        </group>
        <group group_id="P8">
          <title>B-ALL Average Risk-Arm B</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1/29/57; DEX d 1-5/29-33/57-61; high-dose (HD) MTX weekly d 8-78; MP d 1-84; and IT MTX d 1</description>
        </group>
        <group group_id="P9">
          <title>B-ALL Average Risk-Arm C</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1; DEX d 1-5; MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
        </group>
        <group group_id="P10">
          <title>B-ALL Average Risk-Arm D</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1; DEX d 1-5; HD MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Induction</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9298"/>
                <participants group_id="P2" count="52"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3949"/>
                <participants group_id="P2" count="43"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5349"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Refusal</title>
              <participants_list>
                <participants group_id="P1" count="235"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inevaluable</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>BM MRD &gt;= 0.01% on Day 29 of Induction</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>High Risk Downs</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Enrollment onto another COG Protocol</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Average Risk</title>
              <participants_list>
                <participants group_id="P1" count="1847"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>High Risk</title>
              <participants_list>
                <participants group_id="P1" count="1227"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Low Risk</title>
              <participants_list>
                <participants group_id="P1" count="443"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Very High Risk</title>
              <participants_list>
                <participants group_id="P1" count="1012"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Philadelphia chromosome-positive</title>
              <participants_list>
                <participants group_id="P1" count="99"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Incomplete Induction data</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progressive disease</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No treatment</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Ineligible</title>
              <participants_list>
                <participants group_id="P1" count="69"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Post Induction Pre-Maintenance</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="43"/>
                <participants group_id="P3" count="3122"/>
                <participants group_id="P4" count="224"/>
                <participants group_id="P5" count="301"/>
                <participants group_id="P6" count="302"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="37"/>
                <participants group_id="P3" count="2364"/>
                <participants group_id="P4" count="207"/>
                <participants group_id="P5" count="296"/>
                <participants group_id="P6" count="296"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="758"/>
                <participants group_id="P4" count="17"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="6"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="35"/>
                <participants group_id="P4" count="7"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Refusal</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="694"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inevaluable</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>CR failure at the end of consolidation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Progressive disease</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relapse</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Maintenance</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="37"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="207"/>
                <participants group_id="P5" count="296"/>
                <participants group_id="P6" count="296"/>
                <participants group_id="P7" count="600"/>
                <participants group_id="P8" count="586"/>
                <participants group_id="P9" count="586"/>
                <participants group_id="P10" count="592"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="167"/>
                <participants group_id="P5" count="287"/>
                <participants group_id="P6" count="284"/>
                <participants group_id="P7" count="574"/>
                <participants group_id="P8" count="540"/>
                <participants group_id="P9" count="540"/>
                <participants group_id="P10" count="555"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="40"/>
                <participants group_id="P5" count="9"/>
                <participants group_id="P6" count="12"/>
                <participants group_id="P7" count="26"/>
                <participants group_id="P8" count="46"/>
                <participants group_id="P9" count="46"/>
                <participants group_id="P10" count="37"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="2"/>
                <participants group_id="P10" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="9"/>
                <participants group_id="P6" count="4"/>
                <participants group_id="P7" count="8"/>
                <participants group_id="P8" count="8"/>
                <participants group_id="P9" count="10"/>
                <participants group_id="P10" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="4"/>
                <participants group_id="P10" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Refusal</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="4"/>
                <participants group_id="P7" count="5"/>
                <participants group_id="P8" count="17"/>
                <participants group_id="P9" count="13"/>
                <participants group_id="P10" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>second malignant neoplasm</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Inevaluable</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Enrollment onto another COG Protocol</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Relapse</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="6"/>
                <participants group_id="P8" count="13"/>
                <participants group_id="P9" count="11"/>
                <participants group_id="P10" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Still on therapy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="29"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline data were collected according to the Arms from the Induction period (1. B-ALL; 2. B-LLy)</population>
      <group_list>
        <group group_id="B1">
          <title>B-ALL</title>
          <description>All B-ALL patients</description>
        </group>
        <group group_id="B2">
          <title>B-LLy</title>
          <description>All B-LLy patients</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9298"/>
            <count group_id="B2" value="52"/>
            <count group_id="B3" value="9350"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9298"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="9349"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.57" spread="2.12"/>
                    <measurement group_id="B2" value="9.19" spread="4.40"/>
                    <measurement group_id="B3" value="4.59" spread="2.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4294"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="4321"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5004"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="5029"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2132"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="2147"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6726"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="6761"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="440"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="442"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="430"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="431"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="501"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="502"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6857"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="6897"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1308"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="1317"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Disease Free Survival (DFS) in Average Risk (AR) Patients Based on the Methotrexate Dose Randomization</title>
        <description>DFS is calculated as the time from randomization at the end of interim maintenance II to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
        <time_frame>5.7 years</time_frame>
        <population>Average Risk (AR) B-ALL patients who were randomized and started maintenance</population>
        <group_list>
          <group group_id="O1">
            <title>B-ALL Average Risk: MTX 20 mg/m^2/Week Starting Dose</title>
            <description>Cons. (4 wks): vincristine (VIN) day (d) 1; mercaptopurine (MP) d 1-28; IT MTX d 1/8/15; leucovorin (LV) d 3-4/10-11/17-18 Int. maint. I (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 31; LV d 33-34 Delayed-intensification (8 wks): dexamethasone (DEX) d 1-7/15-21; VIN and doxorubicin d 1/8/15; pegaspargase d 4; cyclophosphamide d 29; thioguanine d 29-42; cytarabine d 29-32/33-39; IT MTX d 1/29; LV d 3-4/31-32 Int. maint. II (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 1/31; LV d 3-4/33-34 Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1 Arm A: VIN d 1/29/57; DEX d 1-5/29-33/57-61; MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm B: VIN d 1/29/57; DEX d 1-5/29-33/57-61; high-dose (HD) MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm C: VIN d 1; DEX d 1-5; MTX weekly d 8-78; MP d 1-84; IT MTX d 1 Arm D: VIN d 1; DEX d 1-5; HD MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
          </group>
          <group group_id="O2">
            <title>B-ALL Average Risk: MTX 40 mg/m^2/Week Starting Dose</title>
            <description>Cons. (4 wks): vincristine (VIN) day (d) 1; mercaptopurine (MP) d 1-28; IT MTX d 1/8/15; leucovorin (LV) d 3-4/10-11/17-18 Int. maint. I (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 31; LV d 33-34 Delayed-intensification (8 wks): dexamethasone (DEX) d 1-7/15-21; VIN and doxorubicin d 1/8/15; pegaspargase d 4; cyclophosphamide d 29; thioguanine d 29-42; cytarabine d 29-32/33-39; IT MTX d 1/29; LV d 3-4/31-32 Int. maint. II (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 1/31; LV d 3-4/33-34 Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1 Arm A: VIN d 1/29/57; DEX d 1-5/29-33/57-61; MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm B: VIN d 1/29/57; DEX d 1-5/29-33/57-61; high-dose (HD) MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm C: VIN d 1; DEX d 1-5; MTX weekly d 8-78; MP d 1-84; IT MTX d 1 Arm D: VIN d 1; DEX d 1-5; HD MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
          </group>
        </group_list>
        <measure>
          <title>Disease Free Survival (DFS) in Average Risk (AR) Patients Based on the Methotrexate Dose Randomization</title>
          <description>DFS is calculated as the time from randomization at the end of interim maintenance II to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
          <population>Average Risk (AR) B-ALL patients who were randomized and started maintenance</population>
          <units>percent probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1186"/>
                <count group_id="O2" value="1178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.05" lower_limit="93.27" upper_limit="96.83"/>
                    <measurement group_id="O2" value="94.17" lower_limit="92.23" upper_limit="96.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>DFS in Average Risk (AR) Patients Based on the Pulse Frequency Randomization</title>
        <description>DFS is calculated as the time from randomization at the end of interim maintenance II to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
        <time_frame>5.7 years</time_frame>
        <population>Average Risk (AR) B-ALL patients who were randomized and started maintenance</population>
        <group_list>
          <group group_id="O1">
            <title>B-ALL Average Risk: VCR/DEX Pulse Every 4 Weeks</title>
            <description>Cons. (4 wks): vincristine (VIN) day (d) 1; mercaptopurine (MP) d 1-28; IT MTX d 1/8/15; leucovorin (LV) d 3-4/10-11/17-18 Int. maint. I (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 31; LV d 33-34 Delayed-intensification (8 wks): dexamethasone (DEX) d 1-7/15-21; VIN and doxorubicin d 1/8/15; pegaspargase d 4; cyclophosphamide d 29; thioguanine d 29-42; cytarabine d 29-32/33-39; IT MTX d 1/29; LV d 3-4/31-32 Int. maint. II (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 1/31; LV d 3-4/33-34 Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1 Arm A: VIN d 1/29/57; DEX d 1-5/29-33/57-61; MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm B: VIN d 1/29/57; DEX d 1-5/29-33/57-61; high-dose (HD) MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm C: VIN d 1; DEX d 1-5; MTX weekly d 8-78; MP d 1-84; IT MTX d 1 Arm D: VIN d 1; DEX d 1-5; HD MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
          </group>
          <group group_id="O2">
            <title>B-ALL Average Risk: VCR/DEX Pulse Every 12 Weeks</title>
            <description>Cons. (4 wks): vincristine (VIN) day (d) 1; mercaptopurine (MP) d 1-28; IT MTX d 1/8/15; leucovorin (LV) d 3-4/10-11/17-18 Int. maint. I (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 31; LV d 33-34 Delayed-intensification (8 wks): dexamethasone (DEX) d 1-7/15-21; VIN and doxorubicin d 1/8/15; pegaspargase d 4; cyclophosphamide d 29; thioguanine d 29-42; cytarabine d 29-32/33-39; IT MTX d 1/29; LV d 3-4/31-32 Int. maint. II (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 1/31; LV d 3-4/33-34 Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1 Arm A: VIN d 1/29/57; DEX d 1-5/29-33/57-61; MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm B: VIN d 1/29/57; DEX d 1-5/29-33/57-61; high-dose (HD) MTX weekly d 8-78; MP d 1-84; and IT MTX d 1 Arm C: VIN d 1; DEX d 1-5; MTX weekly d 8-78; MP d 1-84; IT MTX d 1 Arm D: VIN d 1; DEX d 1-5; HD MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
          </group>
        </group_list>
        <measure>
          <title>DFS in Average Risk (AR) Patients Based on the Pulse Frequency Randomization</title>
          <description>DFS is calculated as the time from randomization at the end of interim maintenance II to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
          <population>Average Risk (AR) B-ALL patients who were randomized and started maintenance</population>
          <units>percent probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1186"/>
                <count group_id="O2" value="1178"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.10" lower_limit="92.16" upper_limit="96.04"/>
                    <measurement group_id="O2" value="95.13" lower_limit="93.35" upper_limit="96.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>DFS in Low Risk (LR) Patients Based on Randomization to 1 of 2 Low-intensity Regimens</title>
        <description>DFS is calculated as the time from randomization at the end of Induction to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
        <time_frame>5.1 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>B-ALL Low Risk Arm I (LR-M)</title>
            <description>Consolidation (19 w): vincristine (VIN) day(d) 15/22/78/85; IV/IT methotrexate (MTX) d8/29/50/71/92/113; leucovorin (LV) d9-10/30-31/51-52/72-73/93-94/114-115; dexamethasone (DEX) d15-21/78-84; mercaptopurine (MP) d 1-133. Maint.: VIN d1/8; DEX d1-7; MTX* PO wkly d1-106; MP d 1-112. Repeat every 16 w until 2.5 yrs from dx. IT MTX d1/85 (course 1&amp;4), d 57 (course 2&amp;5), d29 (course 3&amp;6). Course 7: VIN d1/8; DEX d 1-7; MTX PO wkly d8-64; and MP d1-70. *Patients do not receive MTX PO on d w/ IT MTX.</description>
          </group>
          <group group_id="O2">
            <title>B-ALL Low Risk Arm II (LR-C)</title>
            <description>Consolidation (4 w): VIN d1; MP d1-28; IT MTX d1/8/15 Interim Maint. I (8 w): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d31 Delayed-intensification (8 w): DEX d1-7/15-21; VIN &amp; doxorubicin d1/8/15; pegaspargase d4; cyclophosphamide d29; thioguanine d 29-42; cytarabine d29-32/36-39; IT MTX d1/29 Interim Maint. II (8 w): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d1/31 Maint.: VIN d1; DEX d1-5; MTX PO wkly d22-78; MP d 1-84; IT MTX d1. Rpt every 12 w for 2 yrs:girls, 3 yrs:boys from start IM1</description>
          </group>
        </group_list>
        <measure>
          <title>DFS in Low Risk (LR) Patients Based on Randomization to 1 of 2 Low-intensity Regimens</title>
          <description>DFS is calculated as the time from randomization at the end of Induction to first event (relapse, second malignancy, remission death) or date of last contact. Five year DFS estimates will be calculated from the point of randomization for both groups. Two-sided 95% confidence intervals will be calculated.</description>
          <units>percent probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="301"/>
                <count group_id="O2" value="302"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.75" lower_limit="97.14" upper_limit="100.00"/>
                    <measurement group_id="O2" value="98.50" lower_limit="96.75" upper_limit="100.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>DFS for SR Down Syndrome Patients With Standardized Treatment and Enhanced Supportive Care</title>
        <description>DFS is calculated as the time from end of Induction to first event (relapse, second malignancy, remission death) or date of last contact. The 5-year DFS and 95% confidence interval for these patients will be estimated.</description>
        <time_frame>5.1 years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Risk With Down Syndrome</title>
            <description>Consolidation (4 w): vincristine (VIN) d1; MP d1-28; IT methotrexate (MTX) d1/8/15; leucovorin (LV) d3-4/10-11/17-18 Interim maintenance I (8 wks): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d31; LV d36-34 Delayed-intensification (8 wks): Patients receive dexamethasone (DEX) d1-7/15-21; VIN &amp; doxorubicin d1/8/15; pegaspargase d4; cyclophosphamide d29; thioguanine d 29-42; cytarabine d29-32/33-39; IT MTX d1/29; and LV d3-4/31-32 Interim maintenance II (8 wks): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d1/31; and LV d3-4/33-34 Maintenance: VIN d1; DEX d1-5; PO MTX wkly d8-78; MP d1-84; and IT MTX d1. Courses repeat every 12 wks for 2 years (timed from the start of interim maintenance I therapy).</description>
          </group>
        </group_list>
        <measure>
          <title>DFS for SR Down Syndrome Patients With Standardized Treatment and Enhanced Supportive Care</title>
          <description>DFS is calculated as the time from end of Induction to first event (relapse, second malignancy, remission death) or date of last contact. The 5-year DFS and 95% confidence interval for these patients will be estimated.</description>
          <units>percent probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="224"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.77" lower_limit="83.60" upper_limit="95.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sample Collection of Central Path Review Slides in B-LLy Patients</title>
        <description>Percent of B-LLy patients who had adequate/usable samples of samples collected will be reported.</description>
        <time_frame>Up to 1 month</time_frame>
        <population>patients who had samples collected near diagnosis</population>
        <group_list>
          <group group_id="O1">
            <title>B-LLy</title>
            <description>Induction: same trt as B-ALL; Consolidation (4 wks): vincristine sulfate day 1; mercaptopurine days 1-28; IT methotrexate (MTX) days 1/8/15; leucovorin calcium days 3-4,10-11,17-18 Interim maintenance I (8 wks): vincristine sulfate and MTX 2-15 min days 1/11/21/31/41; IT MTX day 31; leucovorin calcium days 33-34 Delayed-intensification (8 wks): dexamethasone days 1-7 and 15-21; vincristine sulfate and doxorubicin hydrochloride on days 1/8/15; pegaspargase 1-2 hrs day 4; cyclophosphamide day 29; thioguanine days 29-42; cytarabine 29-32, 33-39; IT MTX days 1/29; and leucovorin calcium days 3-4, 31-32 Interim maintenance II (8 wks): vincristine sulfate and MTX days 1/11/21/31/41; IT MTX days 1/31; and leucovorin calcium days 3-4, 33/34 Maintenance: vincristine sulfate day 1; dexamethasone days 1-5; MTX weekly days 8-78; mercaptopurine days 1-84; and IT MTX day 1. Courses repeat every 4 wks for 2 yrs (from the start of IMI therapy).</description>
          </group>
        </group_list>
        <measure>
          <title>Sample Collection of Central Path Review Slides in B-LLy Patients</title>
          <description>Percent of B-LLy patients who had adequate/usable samples of samples collected will be reported.</description>
          <population>patients who had samples collected near diagnosis</population>
          <units>percentage of patients</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.7" lower_limit="80.2" upper_limit="99.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Event Free Survival (EFS) for B-LLy Patients</title>
        <description>EFS is calculated as the Time from study enrollment to first event (induction failure, relapse, second malignancy, remission death) or date of last contact. The 5-year EFS and 95% confidence interval for these patients will be estimated.</description>
        <time_frame>5 years</time_frame>
        <population>Ineligible patients are excluded</population>
        <group_list>
          <group group_id="O1">
            <title>B-LLy</title>
            <description>Induction: same trt as B-ALL; Consolidation (4 wks): vincristine sulfate day 1; mercaptopurine days 1-28; IT methotrexate (MTX) days 1/8/15; leucovorin calcium days 3-4,10-11,17-18 Interim maintenance I (8 wks): vincristine sulfate and MTX 2-15 min days 1/11/21/31/41; IT MTX day 31; leucovorin calcium days 33-34 Delayed-intensification (8 wks): dexamethasone days 1-7 and 15-21; vincristine sulfate and doxorubicin hydrochloride on days 1/8/15; pegaspargase 1-2 hrs day 4; cyclophosphamide day 29; thioguanine days 29-42; cytarabine 29-32, 33-39; IT MTX days 1/29; and leucovorin calcium days 3-4, 31-32 Interim maintenance II (8 wks): vincristine sulfate and MTX days 1/11/21/31/41; IT MTX days 1/31; and leucovorin calcium days 3-4, 33/34 Maintenance: vincristine sulfate day 1; dexamethasone days 1-5; MTX weekly days 8-78; mercaptopurine days 1-84; and IT MTX day 1. Courses repeat every 4 wks for 2 yrs (from the start of IMI therapy).</description>
          </group>
        </group_list>
        <measure>
          <title>Event Free Survival (EFS) for B-LLy Patients</title>
          <description>EFS is calculated as the Time from study enrollment to first event (induction failure, relapse, second malignancy, remission death) or date of last contact. The 5-year EFS and 95% confidence interval for these patients will be estimated.</description>
          <population>Ineligible patients are excluded</population>
          <units>percent probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.54" lower_limit="78.17" upper_limit="100.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Survival (OS) for B-LLy Patients</title>
        <description>OS is calculated as the time from study enrollment to death or date of last contact. The 5-year OS and 95% confidence interval for these patients will be estimated.</description>
        <time_frame>5 years</time_frame>
        <population>Ineligible patients are excluded</population>
        <group_list>
          <group group_id="O1">
            <title>B-LLy</title>
            <description>Induction: same trt as B-ALL Consolidation (4 wks): vincristine sulfate day 1; mercaptopurine days 1-28; IT methotrexate (MTX) days 1/8/15; leucovorin calcium days 3-4,10-11,17-18 Interim maintenance I (8 wks): vincristine sulfate and MTX 2-15 min days 1/11/21/31/41; IT MTX day 31; leucovorin calcium days 33-34 Delayed-intensification (8 wks): dexamethasone days 1-7 and 15-21; vincristine sulfate and doxorubicin hydrochloride on days 1/8/15; pegaspargase 1-2 hrs day 4; cyclophosphamide day 29; thioguanine days 29-42; cytarabine 29-32, 33-39; IT MTX days 1/29; and leucovorin calcium days 3-4, 31-32 Interim maintenance II (8 wks): vincristine sulfate and MTX days 1/11/21/31/41; IT MTX days 1/31; and leucovorin calcium days 3-4, 33/34 Maintenance: vincristine sulfate day 1; dexamethasone days 1-5; MTX weekly days 8-78; mercaptopurine days 1-84; and IT MTX day 1. Courses repeat every 4 wks for 2 yrs (from the start of IMI therapy).</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival (OS) for B-LLy Patients</title>
          <description>OS is calculated as the time from study enrollment to death or date of last contact. The 5-year OS and 95% confidence interval for these patients will be estimated.</description>
          <population>Ineligible patients are excluded</population>
          <units>percent probability</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.97" lower_limit="76.88" upper_limit="100.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2 Months</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1 year</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1.7 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2.5 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients Overall at End of Therapy: Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Genetic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>3.2 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2 Months</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1 Year</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1.7 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients Overall at End of Therapy: Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>3.2 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2 Months</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1 Year</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1.7 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2.4 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients Overall at End of Therapy: School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>3.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Consolidation Therapy: Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2 Months</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 1: Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1 Year</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 4: Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>1.7 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients Overall at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients Overall at End of Therapy: Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the Social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated with mean and standard deviation reported.</description>
        <time_frame>3.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
        <time_frame>1.7 years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: Emotional</title>
        <description>Age and gender standardized Quality of life, measured by the emotional subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>3.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
        <time_frame>1.7 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: Physical</title>
        <description>Age and gender standardized Quality of life, measured by the physical subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>3.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
        <time_frame>1.7 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: School</title>
        <description>Age and gender standardized Quality of life, measured by the school subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>3.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 4: Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with means and standard deviation reported.</description>
        <time_frame>1.7 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Burden of Therapy in Boy AR Patients by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Therapy: Social Functioning</title>
        <description>Age and gender standardized Quality of life, measured by the social functioning subscale of Pediatric Quality of Life Inventory 4.0 Generic Core Scales (PedsQL), will be calculated for each group with mean and standard deviation reported.</description>
        <time_frame>3.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Consolidation Therapy-Right</title>
        <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>2 Months</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Consolidation Therapy-Left</title>
        <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>2 Months</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 1: Right</title>
        <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>1 Year</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 1: Left</title>
        <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>1 Year</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Right</title>
        <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Left</title>
        <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL 12 Months Post Therapy: Right</title>
        <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>4.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL 12 Months Post Therapy: Left</title>
        <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for the cohort will be reported.</description>
        <time_frame>4.2 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Right</title>
        <description>Strength in the right ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for each randomization group will be reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Characterize Vincristine-associated Neuropathy in Children Undergoing Therapy for Average Risk (AR) ALL by Vincristine Pulse Frequency Randomization Groups (4 Week vs. 12 Week) at End of Maintenance Cycle 7 (Boys)/End of Therapy (Girls): Left</title>
        <description>Strength in the left ankle dorsiflexors (Kg) averaged over two measurements. Mean and standard deviation for each randomization group will be reported.</description>
        <time_frame>2.4 Years</time_frame>
        <posting_date>12/2020</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 9 years</time_frame>
      <desc>Adverse event reporting is collected routinely using case report forms. The SAE table reflects NCI Common Terminology Criteria for Adverse Events (CTCAEs) submitted by the institution, via expedited reporting (NCI AdEERs / CAeRs). The “AE Other” table reflects all CTCAEs collected excluding those that were reported as SAEs. Ineligible patients are excluded from reporting of adverse events. All-Cause Mortality includes all deaths collected on the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>B-ALL</title>
          <description>All patients receive induction therapy comprising intrathecal (IT) cytarabine on day 1; vincristine sulfate IV on days 1, 8, 15, and 22; dexamethasone orally (PO) or IV twice daily (BID) on days 1-28; pegaspargase IV over 1-2 hours on day 4; and IT methotrexate on days 8 and 29. Patients with DS also receive leucovorin calcium every 12 hours on days 10-11 and 21-32. Patients with Philadelphia chromosome-positive disease are eligible to transfer to COG-AALL0622 by day 15 of induction therapy and patients with high-risk (HR) or very high-risk (VHR) disease are eligible to transfer to a COG HR or VHR trial at the end of induction therapy. Patients with standard-risk disease with Down syndrome (DS) who have bone marrow minimal residual disease 0.01% are eligible to transfer to the DS stratum of the HR trial. Patients with induction failure (defined as M3 [&gt; 25% lymphoblasts] on day 29) may be eligible for the COG VHR-acute lymphoblastic leukemia study.</description>
        </group>
        <group group_id="E2">
          <title>B-LLy</title>
          <description>Induction: same trt as B-ALL; Consolidation (4 wks): vincristine sulfate day 1; mercaptopurine days 1-28; IT methotrexate (MTX) days 1/8/15; leucovorin calcium days 3-4,10-11,17-18 Interim maintenance I (8 wks): vincristine sulfate and MTX 2-15 min days 1/11/21/31/41; IT MTX day 31; leucovorin calcium days 33-34 Delayed-intensification (8 wks): dexamethasone days 1-7 and 15-21; vincristine sulfate and doxorubicin hydrochloride on days 1/8/15; pegaspargase 1-2 hrs day 4; cyclophosphamide day 29; thioguanine days 29-42; cytarabine 29-32, 33-39; IT MTX days 1/29; and leucovorin calcium days 3-4, 31-32 Interim maintenance II (8 wks): vincristine sulfate and MTX days 1/11/21/31/41; IT MTX days 1/31; and leucovorin calcium days 3-4, 33/34 Maintenance: vincristine sulfate day 1; dexamethasone days 1-5; MTX weekly days 8-78; mercaptopurine days 1-84; and IT MTX day 1. Courses repeat every 4 wks for 2 yrs (from the start of IMI therapy).</description>
        </group>
        <group group_id="E3">
          <title>B-ALL Average Risk</title>
          <description>Consolidation (4 wks): vincristine (VIN) day (d) 1; mercaptopurine (MP) d 1-28; IT MTX d 1/8/15; leucovorin (LV) d 3-4/10-11/17-18 Int. maint. I (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 31; LV d 33-34 Delayed-intensification (8 wks): dexamethasone (DEX) d 1-7/15-21; VIN and doxorubicin d 1/8/15; pegaspargase d 4; cyclophosphamide d 29; thioguanine d 29-42; cytarabine d 29-32/33-39; IT MTX d 1/29; LV d 3-4/31-32 Int. maint. II (8 wks): VIN and MTX d 1/11/21/31/41; IT MTX d 1/31; LV d 3-4/33-34</description>
        </group>
        <group group_id="E4">
          <title>Standard Risk With Down Syndrome</title>
          <description>Consolidation (4 w): vincristine (VIN) d1; MP d1-28; IT methotrexate (MTX) d1/8/15; leucovorin (LV) d3-4/10-11/17-18 Interim maintenance I (8 wks): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d31; LV d36-34 Delayed-intensification (8 wks): Patients receive dexamethasone (DEX) d1-7/15-21; VIN &amp; doxorubicin d1/8/15; pegaspargase d4; cyclophosphamide d29; thioguanine d 29-42; cytarabine d29-32/33-39; IT MTX d1/29; and LV d3-4/31-32 Interim maintenance II (8 wks): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d1/31; and LV d3-4/33-34 Maintenance: VIN d1; DEX d1-5; PO MTX wkly d8-78; MP d1-84; and IT MTX d1. Courses repeat every 12 wks for 2 years (timed from the start of interim maintenance I therapy).</description>
        </group>
        <group group_id="E5">
          <title>B-ALL Low Risk Arm I (LR-M)</title>
          <description>Consolidation (19 w): vincristine (VIN) day(d) 15/22/78/85; IV/IT methotrexate (MTX) d8/29/50/71/92/113; leucovorin (LV) d9-10/30-31/51-52/72-73/93-94/114-115; dexamethasone (DEX) d15-21/78-84; mercaptopurine (MP) d 1-133. Maint.: VIN d1/8; DEX d1-7; MTX* PO wkly d1-106; MP d 1-112. Repeat every 16 w until 2.5 yrs from dx. IT MTX d1/85 (course 1&amp;4), d 57 (course 2&amp;5), d29 (course 3&amp;6). Course 7: VIN d1/8; DEX d 1-7; MTX PO wkly d8-64; and MP d1-70. *Patients do not receive MTX PO on d w/ IT MTX.</description>
        </group>
        <group group_id="E6">
          <title>B-ALL Low Risk Arm II (LR-C)</title>
          <description>Consolidation (4 w): VIN d1; MP d1-28; IT MTX d1/8/15 Interim Maint. I (8 w): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d31 Delayed-intensification (8 w): DEX d1-7/15-21; VIN &amp; doxorubicin d1/8/15; pegaspargase d4; cyclophosphamide d29; thioguanine d 29-42; cytarabine d29-32/36-39; IT MTX d1/29 Interim Maint. II (8 w): VIN &amp; IV MTX d1/11/21/31/41; IT MTX d1/31 Maint.: VIN d1; DEX d1-5; MTX PO wkly d22-78; MP d 1-84; IT MTX d1. Rpt every 12 w for 2 yrs:girls, 3 yrs:boys from start IM1</description>
        </group>
        <group group_id="E7">
          <title>B-ALL Average Risk-Arm A</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1/29/57; DEX d 1-5/29-33/57-61; MTX weekly d 8-78; MP d 1+P8:W8-84; and IT MTX d 1</description>
        </group>
        <group group_id="E8">
          <title>B-ALL Average Risk-Arm B</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1/29/57; DEX d 1-5/29-33/57-61; high-dose (HD) MTX weekly d 8-78; MP d 1-84; and IT MTX d 1</description>
        </group>
        <group group_id="E9">
          <title>B-ALL Average Risk-Arm C</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1; DEX d 1-5; MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
        </group>
        <group group_id="E10">
          <title>B-ALL Average Risk-Arm D</title>
          <description>Maintenance: repeat every 12 wks for 2 yrs (girls), 3 yrs (boys) from start IM1: VIN d 1; DEX d 1-5; HD MTX weekly d 8-78; MP d 1-84; IT MTX d 1</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>CTCv4</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="125" subjects_at_risk="9229"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="3122"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="224"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="600"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="586"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="586"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="9229"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="3122"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="600"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="586"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="586"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Blood and lymphatic system disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Heart failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Colonic perforation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastric hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorders - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastrointestinal pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ileal hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ileal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ileal ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Mucositis oral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pancreatic necrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Small intestinal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Typhlitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death NOS</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sudden death NOS</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylaxis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Immune system disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Catheter related infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cecal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hepatitis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Infections and infestations - Other, specify</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Mucosal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Periorbital infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Peritoneal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cholesterol high</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Neutrophil count decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>White blood cell decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypoalbuminemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypophosphatemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Muscle weakness lower limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Treatment related secondary malignancy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Edema cerebral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Intracranial hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Nervous system disorders - Other, specify</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Reversible posterior leukoencephalopathy syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Personality change</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Renal and urinary disorders - Other, specify</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Renal calculi</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Adult respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Apnea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bronchopulmonary hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pulmonary edema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sinus disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Toxic epidermal necrolysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Surgical and medical procedures - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Thromboembolic event</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>CTCv4</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1776" subjects_at_risk="9229"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="48"/>
                <counts group_id="E3" subjects_affected="1037" subjects_at_risk="3122"/>
                <counts group_id="E4" subjects_affected="191" subjects_at_risk="224"/>
                <counts group_id="E5" subjects_affected="103" subjects_at_risk="301"/>
                <counts group_id="E6" subjects_affected="143" subjects_at_risk="302"/>
                <counts group_id="E7" subjects_affected="180" subjects_at_risk="600"/>
                <counts group_id="E8" subjects_affected="204" subjects_at_risk="586"/>
                <counts group_id="E9" subjects_affected="156" subjects_at_risk="586"/>
                <counts group_id="E10" subjects_affected="152" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="21" subjects_affected="19" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="301"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Blood and lymphatic system disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bone marrow hypocellular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" events="114" subjects_affected="114" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="112" subjects_affected="101" subjects_at_risk="3122"/>
                <counts group_id="E4" events="185" subjects_affected="114" subjects_at_risk="224"/>
                <counts group_id="E5" events="15" subjects_affected="13" subjects_at_risk="301"/>
                <counts group_id="E6" events="16" subjects_affected="14" subjects_at_risk="302"/>
                <counts group_id="E7" events="34" subjects_affected="28" subjects_at_risk="600"/>
                <counts group_id="E8" events="40" subjects_affected="35" subjects_at_risk="586"/>
                <counts group_id="E9" events="26" subjects_affected="23" subjects_at_risk="586"/>
                <counts group_id="E10" events="32" subjects_affected="27" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hemolytic uremic syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cardiac disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Heart failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Wolff-Parkinson-White syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Congenital, familial and genetic disorders - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear and labyrinth disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hearing impaired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cushingoid</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Endocrine disorders - Other, specify</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Eye disorders - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Optic nerve disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vitreous hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anal hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anal mucositis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anal necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anal ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cecal hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="8" subjects_affected="7" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Colonic hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Colonic obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Colonic perforation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Duodenal perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Enterocolitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastric hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastric necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastric perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorders - Other, specify</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gastrointestinal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ileal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ileal perforation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="34" subjects_affected="34" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="3122"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Jejunal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Jejunal perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Malabsorption</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Mucositis oral</sub_title>
                <counts group_id="E1" events="70" subjects_affected="70" subjects_at_risk="9229"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="48"/>
                <counts group_id="E3" events="374" subjects_affected="354" subjects_at_risk="3122"/>
                <counts group_id="E4" events="120" subjects_affected="88" subjects_at_risk="224"/>
                <counts group_id="E5" events="25" subjects_affected="21" subjects_at_risk="301"/>
                <counts group_id="E6" events="46" subjects_affected="38" subjects_at_risk="302"/>
                <counts group_id="E7" events="19" subjects_affected="18" subjects_at_risk="600"/>
                <counts group_id="E8" events="25" subjects_affected="22" subjects_at_risk="586"/>
                <counts group_id="E9" events="16" subjects_affected="15" subjects_at_risk="586"/>
                <counts group_id="E10" events="13" subjects_affected="12" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Oral pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pancreatic necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="90" subjects_affected="90" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="15" subjects_affected="15" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="8" subjects_affected="4" subjects_at_risk="302"/>
                <counts group_id="E7" events="8" subjects_affected="5" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="8" subjects_affected="3" subjects_at_risk="586"/>
                <counts group_id="E10" events="5" subjects_affected="4" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Rectal mucositis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Rectal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Rectal perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Small intestinal mucositis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Small intestinal perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Typhlitis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="43" subjects_affected="36" subjects_at_risk="3122"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E5" events="6" subjects_affected="6" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="10" subjects_affected="7" subjects_at_risk="600"/>
                <counts group_id="E8" events="4" subjects_affected="3" subjects_at_risk="586"/>
                <counts group_id="E9" events="6" subjects_affected="6" subjects_at_risk="586"/>
                <counts group_id="E10" events="10" subjects_affected="8" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Flu like symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Infusion related reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Localized edema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gallbladder pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hepatobiliary disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Portal hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="50" subjects_affected="50" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="6" subjects_affected="6" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anaphylaxis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="9229"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E3" events="21" subjects_affected="21" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Immune system disorders - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anorectal infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bladder infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bone infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bronchial infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Catheter related infection</sub_title>
                <counts group_id="E1" events="44" subjects_affected="44" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="3122"/>
                <counts group_id="E4" events="11" subjects_affected="8" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cecal infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="6" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Encephalitis infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Endocarditis infective</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Enterocolitis infectious</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Esophageal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Gum infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hepatic infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hepatitis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Infections and infestations - Other, specify</sub_title>
                <counts group_id="E1" events="125" subjects_affected="122" subjects_at_risk="9229"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E3" events="50" subjects_affected="48" subjects_at_risk="3122"/>
                <counts group_id="E4" events="77" subjects_affected="62" subjects_at_risk="224"/>
                <counts group_id="E5" events="6" subjects_affected="6" subjects_at_risk="301"/>
                <counts group_id="E6" events="6" subjects_affected="5" subjects_at_risk="302"/>
                <counts group_id="E7" events="12" subjects_affected="12" subjects_at_risk="600"/>
                <counts group_id="E8" events="7" subjects_affected="6" subjects_at_risk="586"/>
                <counts group_id="E9" events="14" subjects_affected="13" subjects_at_risk="586"/>
                <counts group_id="E10" events="12" subjects_affected="11" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Infective myositis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Lip infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="3122"/>
                <counts group_id="E4" events="53" subjects_affected="42" subjects_at_risk="224"/>
                <counts group_id="E5" events="5" subjects_affected="5" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="6" subjects_affected="6" subjects_at_risk="600"/>
                <counts group_id="E8" events="6" subjects_affected="6" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Lymph gland infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Mediastinal infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Mucosal infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="3122"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="7" subjects_affected="6" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pancreas infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Papulopustular rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Periorbital infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Peripheral nerve infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Peritoneal infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Rash pustular</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Scrotal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="100" subjects_affected="100" subjects_at_risk="9229"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E3" events="22" subjects_affected="22" subjects_at_risk="3122"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="224"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="6" subjects_affected="6" subjects_at_risk="600"/>
                <counts group_id="E8" events="10" subjects_affected="10" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="25" subjects_affected="22" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="5" subjects_affected="4" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Small intestine infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Soft tissue infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Stoma site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Upper respiratory infection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="24" subjects_affected="23" subjects_at_risk="3122"/>
                <counts group_id="E4" events="66" subjects_affected="49" subjects_at_risk="224"/>
                <counts group_id="E5" events="8" subjects_affected="4" subjects_at_risk="301"/>
                <counts group_id="E6" events="5" subjects_affected="5" subjects_at_risk="302"/>
                <counts group_id="E7" events="8" subjects_affected="7" subjects_at_risk="600"/>
                <counts group_id="E8" events="10" subjects_affected="8" subjects_at_risk="586"/>
                <counts group_id="E9" events="6" subjects_affected="6" subjects_at_risk="586"/>
                <counts group_id="E10" events="13" subjects_affected="10" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urethral infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="3122"/>
                <counts group_id="E4" events="15" subjects_affected="11" subjects_at_risk="224"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="4" subjects_affected="4" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="7" subjects_affected="5" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Injury, poisoning and procedural complications - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Tracheal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vascular access complication</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Wound dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Activated partial thromboplastin time prolonged</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" events="195" subjects_affected="195" subjects_at_risk="9229"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="48"/>
                <counts group_id="E3" events="160" subjects_affected="139" subjects_at_risk="3122"/>
                <counts group_id="E4" events="31" subjects_affected="22" subjects_at_risk="224"/>
                <counts group_id="E5" events="45" subjects_affected="29" subjects_at_risk="301"/>
                <counts group_id="E6" events="38" subjects_affected="28" subjects_at_risk="302"/>
                <counts group_id="E7" events="56" subjects_affected="42" subjects_at_risk="600"/>
                <counts group_id="E8" events="61" subjects_affected="46" subjects_at_risk="586"/>
                <counts group_id="E9" events="43" subjects_affected="36" subjects_at_risk="586"/>
                <counts group_id="E10" events="51" subjects_affected="37" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Alkaline phosphatase increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" events="73" subjects_affected="72" subjects_at_risk="9229"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E3" events="23" subjects_affected="22" subjects_at_risk="3122"/>
                <counts group_id="E4" events="9" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E5" events="5" subjects_affected="5" subjects_at_risk="301"/>
                <counts group_id="E6" events="6" subjects_affected="5" subjects_at_risk="302"/>
                <counts group_id="E7" events="12" subjects_affected="11" subjects_at_risk="600"/>
                <counts group_id="E8" events="5" subjects_affected="5" subjects_at_risk="586"/>
                <counts group_id="E9" events="8" subjects_affected="7" subjects_at_risk="586"/>
                <counts group_id="E10" events="7" subjects_affected="6" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" events="111" subjects_affected="111" subjects_at_risk="9229"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="48"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="3122"/>
                <counts group_id="E4" events="16" subjects_affected="12" subjects_at_risk="224"/>
                <counts group_id="E5" events="25" subjects_affected="20" subjects_at_risk="301"/>
                <counts group_id="E6" events="18" subjects_affected="16" subjects_at_risk="302"/>
                <counts group_id="E7" events="40" subjects_affected="37" subjects_at_risk="600"/>
                <counts group_id="E8" events="49" subjects_affected="36" subjects_at_risk="586"/>
                <counts group_id="E9" events="61" subjects_affected="33" subjects_at_risk="586"/>
                <counts group_id="E10" events="44" subjects_affected="32" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cholesterol high</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Creatinine increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Fibrinogen decreased</sub_title>
                <counts group_id="E1" events="55" subjects_affected="55" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>GGT increased</sub_title>
                <counts group_id="E1" events="34" subjects_affected="34" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Investigations - Other, specify</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Lipase increased</sub_title>
                <counts group_id="E1" events="40" subjects_affected="39" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="3" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="5" subjects_affected="4" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Lymphocyte count decreased</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="3" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Neutrophil count decreased</sub_title>
                <counts group_id="E1" events="339" subjects_affected="333" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="259" subjects_affected="201" subjects_at_risk="3122"/>
                <counts group_id="E4" events="203" subjects_affected="102" subjects_at_risk="224"/>
                <counts group_id="E5" events="25" subjects_affected="14" subjects_at_risk="301"/>
                <counts group_id="E6" events="31" subjects_affected="23" subjects_at_risk="302"/>
                <counts group_id="E7" events="43" subjects_affected="27" subjects_at_risk="600"/>
                <counts group_id="E8" events="59" subjects_affected="40" subjects_at_risk="586"/>
                <counts group_id="E9" events="38" subjects_affected="29" subjects_at_risk="586"/>
                <counts group_id="E10" events="58" subjects_affected="39" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" events="161" subjects_affected="161" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="40" subjects_affected="38" subjects_at_risk="3122"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="3" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Serum amylase increased</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Weight gain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Weight loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>White blood cell decreased</sub_title>
                <counts group_id="E1" events="142" subjects_affected="141" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="44" subjects_affected="41" subjects_at_risk="3122"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="301"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="7" subjects_affected="6" subjects_at_risk="586"/>
                <counts group_id="E9" events="3" subjects_affected="3" subjects_at_risk="586"/>
                <counts group_id="E10" events="6" subjects_affected="5" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Alkalosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="3122"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="3122"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="3" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Glucose intolerance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" events="147" subjects_affected="147" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="5" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="301"/>
                <counts group_id="E6" events="3" subjects_affected="3" subjects_at_risk="302"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypernatremia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypertriglyceridemia</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hyperuricemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypoalbuminemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypocalcemia</sub_title>
                <counts group_id="E1" events="41" subjects_affected="41" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="3122"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="4" subjects_affected="3" subjects_at_risk="301"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="302"/>
                <counts group_id="E7" events="4" subjects_affected="4" subjects_at_risk="600"/>
                <counts group_id="E8" events="7" subjects_affected="6" subjects_at_risk="586"/>
                <counts group_id="E9" events="4" subjects_affected="4" subjects_at_risk="586"/>
                <counts group_id="E10" events="6" subjects_affected="6" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" events="79" subjects_affected="79" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="40" subjects_affected="34" subjects_at_risk="3122"/>
                <counts group_id="E4" events="8" subjects_affected="8" subjects_at_risk="224"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="301"/>
                <counts group_id="E6" events="7" subjects_affected="7" subjects_at_risk="302"/>
                <counts group_id="E7" events="5" subjects_affected="4" subjects_at_risk="600"/>
                <counts group_id="E8" events="7" subjects_affected="7" subjects_at_risk="586"/>
                <counts group_id="E9" events="4" subjects_affected="3" subjects_at_risk="586"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypomagnesemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypophosphatemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Metabolism and nutrition disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Tumor lysis syndrome</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Avascular necrosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="301"/>
                <counts group_id="E6" events="6" subjects_affected="6" subjects_at_risk="302"/>
                <counts group_id="E7" events="6" subjects_affected="6" subjects_at_risk="600"/>
                <counts group_id="E8" events="10" subjects_affected="10" subjects_at_risk="586"/>
                <counts group_id="E9" events="8" subjects_affected="7" subjects_at_risk="586"/>
                <counts group_id="E10" events="5" subjects_affected="5" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Generalized muscle weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Muscle weakness left-sided</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Muscle weakness lower limb</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Muscle weakness right-sided</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Musculoskeletal and connective tissue disorder - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Myositis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Soft tissue necrosis lower limb</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Soft tissue necrosis upper limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Akathisia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Arachnoiditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Central nervous system necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cerebrospinal fluid leakage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dysphasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Facial muscle weakness</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="2" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Intracranial hemorrhage</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Ischemia cerebrovascular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Leukoencephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Movements involuntary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Nervous system disorders - Other, specify</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Oculomotor nerve disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Paresthesia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Peripheral motor neuropathy</sub_title>
                <counts group_id="E1" events="175" subjects_affected="175" subjects_at_risk="9229"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E3" events="109" subjects_affected="98" subjects_at_risk="3122"/>
                <counts group_id="E4" events="15" subjects_affected="14" subjects_at_risk="224"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="301"/>
                <counts group_id="E6" events="9" subjects_affected="9" subjects_at_risk="302"/>
                <counts group_id="E7" events="13" subjects_affected="8" subjects_at_risk="600"/>
                <counts group_id="E8" events="17" subjects_affected="14" subjects_at_risk="586"/>
                <counts group_id="E9" events="5" subjects_affected="5" subjects_at_risk="586"/>
                <counts group_id="E10" events="5" subjects_affected="4" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" events="151" subjects_affected="151" subjects_at_risk="9229"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E3" events="83" subjects_affected="69" subjects_at_risk="3122"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="224"/>
                <counts group_id="E5" events="8" subjects_affected="5" subjects_at_risk="301"/>
                <counts group_id="E6" events="15" subjects_affected="9" subjects_at_risk="302"/>
                <counts group_id="E7" events="20" subjects_affected="10" subjects_at_risk="600"/>
                <counts group_id="E8" events="27" subjects_affected="17" subjects_at_risk="586"/>
                <counts group_id="E9" events="8" subjects_affected="8" subjects_at_risk="586"/>
                <counts group_id="E10" events="7" subjects_affected="7" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Recurrent laryngeal nerve palsy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Reversible posterior leukoencephalopathy syndrome</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="69" subjects_affected="69" subjects_at_risk="9229"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E3" events="59" subjects_affected="52" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="301"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="302"/>
                <counts group_id="E7" events="12" subjects_affected="6" subjects_at_risk="600"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="586"/>
                <counts group_id="E9" events="4" subjects_affected="4" subjects_at_risk="586"/>
                <counts group_id="E10" events="11" subjects_affected="10" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Transient ischemic attacks</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vasovagal reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Personality change</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Psychosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Renal and urinary disorders - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Renal calculi</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urinary frequency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urinary tract obstruction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urinary tract pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urinary urgency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Reproductive system and breast disorders - Other, specify</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Scrotal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Adult respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Apnea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bronchial stricture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hoarseness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="3122"/>
                <counts group_id="E4" events="10" subjects_affected="9" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Laryngeal edema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pulmonary edema</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="3122"/>
                <counts group_id="E4" events="6" subjects_affected="6" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="3" subjects_affected="3" subjects_at_risk="600"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="586"/>
                <counts group_id="E10" events="3" subjects_affected="3" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Respiratory, thoracic and mediastinal disorders - Other, specify</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Stridor</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Tracheal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema multiforme</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Palmar-plantar erythrodysesthesia syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Periorbital edema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Photosensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Rash acneiform</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="2" subjects_affected="2" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Skin and subcutaneous tissue disorders - Other, specify</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Skin ulceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Surgical and medical procedures - Other, specify</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Capillary leak syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9229"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="3122"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="224"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="301"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="302"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Peripheral ischemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Thromboembolic event</sub_title>
                <counts group_id="E1" events="56" subjects_affected="55" subjects_at_risk="9229"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E3" events="17" subjects_affected="15" subjects_at_risk="3122"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
              <event>
                <sub_title>Vascular disorders - Other, specify</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="9229"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="3122"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="224"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="301"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="302"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="600"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="586"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="592"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Must obtain prior Sponsor approval</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Results Reporting Coordinator</name_or_title>
      <organization>Children's Oncology Group</organization>
      <phone>626-447-0064</phone>
      <email>resultsreportingcoordinator@childrensoncologygroup.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

